nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ABCB1—adrenal gland cancer	0.736	1	CbGaD
Risperidone—HTR7—sympathetic nervous system—adrenal gland cancer	0.0107	0.133	CbGeAlD
Risperidone—HTR7—vein—adrenal gland cancer	0.01	0.124	CbGeAlD
Risperidone—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00667	0.0828	CbGeAlD
Risperidone—HTR2A—vein—adrenal gland cancer	0.00624	0.0775	CbGeAlD
Risperidone—HTR2A—urine—adrenal gland cancer	0.00365	0.0454	CbGeAlD
Risperidone—CYP3A4—urine—adrenal gland cancer	0.00338	0.042	CbGeAlD
Risperidone—CYP2D6—urine—adrenal gland cancer	0.00333	0.0413	CbGeAlD
Risperidone—H1F0—adrenal cortex—adrenal gland cancer	0.00252	0.0312	CbGeAlD
Risperidone—H1F0—gonad—adrenal gland cancer	0.00208	0.0259	CbGeAlD
Risperidone—H1F0—cardiac atrium—adrenal gland cancer	0.00208	0.0258	CbGeAlD
Risperidone—H1F0—pituitary gland—adrenal gland cancer	0.00203	0.0252	CbGeAlD
Risperidone—H1F0—adrenal gland—adrenal gland cancer	0.00182	0.0225	CbGeAlD
Risperidone—HTR2B—adrenal cortex—adrenal gland cancer	0.00181	0.0225	CbGeAlD
Risperidone—ADRA2C—adrenal cortex—adrenal gland cancer	0.00143	0.0177	CbGeAlD
Risperidone—HTR2B—adrenal gland—adrenal gland cancer	0.00131	0.0162	CbGeAlD
Risperidone—HTR7—gonad—adrenal gland cancer	0.00129	0.016	CbGeAlD
Risperidone—KCNH2—cardiac atrium—adrenal gland cancer	0.0012	0.0149	CbGeAlD
Risperidone—DRD2—pituitary gland—adrenal gland cancer	0.00119	0.0147	CbGeAlD
Risperidone—ADRA2C—cardiac atrium—adrenal gland cancer	0.00118	0.0147	CbGeAlD
Risperidone—HTR1A—adrenal gland—adrenal gland cancer	0.00117	0.0146	CbGeAlD
Risperidone—KCNH2—pituitary gland—adrenal gland cancer	0.00117	0.0145	CbGeAlD
Risperidone—ADRA2C—pituitary gland—adrenal gland cancer	0.00115	0.0143	CbGeAlD
Risperidone—HTR7—adrenal gland—adrenal gland cancer	0.00112	0.0139	CbGeAlD
Risperidone—ADRA1A—adrenal gland—adrenal gland cancer	0.00108	0.0134	CbGeAlD
Risperidone—KCNH2—adrenal gland—adrenal gland cancer	0.00104	0.013	CbGeAlD
Risperidone—ADRA2C—adrenal gland—adrenal gland cancer	0.00103	0.0128	CbGeAlD
Risperidone—ADRA2A—gonad—adrenal gland cancer	0.000943	0.0117	CbGeAlD
Risperidone—ADRA2A—cardiac atrium—adrenal gland cancer	0.000942	0.0117	CbGeAlD
Risperidone—ADRA2A—pituitary gland—adrenal gland cancer	0.00092	0.0114	CbGeAlD
Risperidone—HRH1—adrenal gland—adrenal gland cancer	0.000837	0.0104	CbGeAlD
Risperidone—ADRA2A—adrenal gland—adrenal gland cancer	0.000822	0.0102	CbGeAlD
Risperidone—HTR2A—gonad—adrenal gland cancer	0.000802	0.00995	CbGeAlD
Risperidone—HTR2A—pituitary gland—adrenal gland cancer	0.000782	0.00971	CbGeAlD
Risperidone—HTR2A—adrenal gland—adrenal gland cancer	0.000699	0.00868	CbGeAlD
Risperidone—ABCB1—adrenal cortex—adrenal gland cancer	0.000635	0.00788	CbGeAlD
Risperidone—ABCB1—gonad—adrenal gland cancer	0.000526	0.00652	CbGeAlD
Risperidone—ABCB1—pituitary gland—adrenal gland cancer	0.000513	0.00636	CbGeAlD
Risperidone—ABCB1—adrenal gland—adrenal gland cancer	0.000458	0.00569	CbGeAlD
Risperidone—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	4.72e-05	0.000257	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	4.71e-05	0.000257	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	4.66e-05	0.000254	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	4.65e-05	0.000254	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	4.63e-05	0.000253	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	4.63e-05	0.000252	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—GNAS—adrenal gland cancer	4.62e-05	0.000252	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	4.57e-05	0.00025	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	4.55e-05	0.000248	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	4.54e-05	0.000248	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	4.53e-05	0.000247	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	4.51e-05	0.000246	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	4.49e-05	0.000245	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	4.48e-05	0.000245	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—GNAS—adrenal gland cancer	4.48e-05	0.000245	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	4.45e-05	0.000243	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	4.42e-05	0.000241	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	4.4e-05	0.00024	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	4.39e-05	0.00024	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	4.39e-05	0.00024	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TERT—adrenal gland cancer	4.39e-05	0.00024	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	4.36e-05	0.000238	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	4.34e-05	0.000237	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.33e-05	0.000236	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	4.27e-05	0.000233	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	4.27e-05	0.000233	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	4.27e-05	0.000233	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MED12—adrenal gland cancer	4.26e-05	0.000232	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	4.21e-05	0.00023	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TERT—adrenal gland cancer	4.2e-05	0.000229	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	4.2e-05	0.000229	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	4.2e-05	0.000229	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	4.2e-05	0.000229	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	4.19e-05	0.000229	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	4.13e-05	0.000225	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	4.12e-05	0.000225	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	4.12e-05	0.000225	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	4.11e-05	0.000224	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	4.05e-05	0.000221	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	4.05e-05	0.000221	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	4.04e-05	0.000221	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	4.03e-05	0.00022	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MED12—adrenal gland cancer	4.01e-05	0.000219	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	4.01e-05	0.000219	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	4.01e-05	0.000219	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	3.92e-05	0.000214	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	3.91e-05	0.000214	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	3.91e-05	0.000213	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	3.89e-05	0.000212	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.88e-05	0.000212	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	3.87e-05	0.000211	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	3.86e-05	0.000211	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	3.85e-05	0.00021	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	3.82e-05	0.000209	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—BAD—adrenal gland cancer	3.82e-05	0.000208	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	3.82e-05	0.000208	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	3.81e-05	0.000208	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	3.79e-05	0.000207	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—TP53—adrenal gland cancer	3.78e-05	0.000207	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TERT—adrenal gland cancer	3.78e-05	0.000206	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	3.78e-05	0.000206	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.78e-05	0.000206	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	3.76e-05	0.000205	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	3.76e-05	0.000205	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	3.75e-05	0.000205	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	3.74e-05	0.000204	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TERT—adrenal gland cancer	3.73e-05	0.000204	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	3.72e-05	0.000203	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	3.71e-05	0.000203	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	3.69e-05	0.000201	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	3.66e-05	0.0002	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—BAD—adrenal gland cancer	3.66e-05	0.000199	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GNAS—adrenal gland cancer	3.64e-05	0.000199	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	3.6e-05	0.000196	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	3.57e-05	0.000195	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.56e-05	0.000194	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—TP53—adrenal gland cancer	3.53e-05	0.000193	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—POMC—adrenal gland cancer	3.52e-05	0.000192	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.52e-05	0.000192	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.52e-05	0.000192	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.5e-05	0.000191	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	3.5e-05	0.000191	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.5e-05	0.000191	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	3.49e-05	0.00019	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	3.48e-05	0.00019	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	3.47e-05	0.000189	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	3.45e-05	0.000188	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.43e-05	0.000187	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	3.43e-05	0.000187	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	3.42e-05	0.000187	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.4e-05	0.000186	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	3.38e-05	0.000185	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	3.38e-05	0.000184	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—POMC—adrenal gland cancer	3.37e-05	0.000184	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	3.37e-05	0.000184	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	3.37e-05	0.000184	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	3.37e-05	0.000184	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	3.35e-05	0.000183	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	3.35e-05	0.000183	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	3.34e-05	0.000182	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	3.34e-05	0.000182	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	3.33e-05	0.000182	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.32e-05	0.000181	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	3.31e-05	0.00018	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—BAD—adrenal gland cancer	3.29e-05	0.00018	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	3.28e-05	0.000179	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	3.28e-05	0.000179	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	3.27e-05	0.000179	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	3.26e-05	0.000178	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	3.26e-05	0.000178	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	3.25e-05	0.000178	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—BAD—adrenal gland cancer	3.25e-05	0.000177	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	3.24e-05	0.000177	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	3.23e-05	0.000176	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	3.22e-05	0.000176	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.2e-05	0.000174	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	3.19e-05	0.000174	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	3.18e-05	0.000173	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	3.15e-05	0.000172	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—POMC—adrenal gland cancer	3.11e-05	0.00017	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.11e-05	0.00017	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	3.1e-05	0.000169	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	3.08e-05	0.000168	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	3.07e-05	0.000168	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	3.05e-05	0.000166	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—POMC—adrenal gland cancer	3.03e-05	0.000166	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—POMC—adrenal gland cancer	3.02e-05	0.000165	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	3e-05	0.000163	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—POMC—adrenal gland cancer	2.99e-05	0.000163	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.97e-05	0.000162	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	2.96e-05	0.000161	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	2.93e-05	0.00016	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.93e-05	0.00016	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	2.9e-05	0.000158	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—adrenal gland cancer	2.87e-05	0.000157	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	2.86e-05	0.000156	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.86e-05	0.000156	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.83e-05	0.000154	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	2.82e-05	0.000154	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.81e-05	0.000153	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.8e-05	0.000153	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.75e-05	0.00015	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	2.74e-05	0.000149	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	2.7e-05	0.000147	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	2.69e-05	0.000147	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	2.67e-05	0.000146	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.62e-05	0.000143	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	2.61e-05	0.000142	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	2.6e-05	0.000142	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	2.59e-05	0.000141	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	2.58e-05	0.000141	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	2.56e-05	0.00014	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	2.56e-05	0.00014	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	2.52e-05	0.000138	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.52e-05	0.000137	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	2.51e-05	0.000137	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.5e-05	0.000136	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	2.5e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	2.49e-05	0.000136	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.48e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	2.48e-05	0.000136	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.48e-05	0.000136	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	2.48e-05	0.000135	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	2.45e-05	0.000134	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—POMC—adrenal gland cancer	2.45e-05	0.000134	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.44e-05	0.000133	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.44e-05	0.000133	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.44e-05	0.000133	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.42e-05	0.000132	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	2.41e-05	0.000131	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.41e-05	0.000131	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	2.39e-05	0.000131	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	2.38e-05	0.00013	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.37e-05	0.00013	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.33e-05	0.000127	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.3e-05	0.000125	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.29e-05	0.000125	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.26e-05	0.000123	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	2.25e-05	0.000123	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—POMC—adrenal gland cancer	2.25e-05	0.000123	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—POMC—adrenal gland cancer	2.25e-05	0.000123	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	2.23e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	2.22e-05	0.000121	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	2.22e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	2.21e-05	0.00012	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.19e-05	0.00012	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	2.18e-05	0.000119	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.17e-05	0.000118	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	2.16e-05	0.000118	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	2.15e-05	0.000117	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	2.14e-05	0.000117	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.11e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	2.05e-05	0.000112	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	2.02e-05	0.00011	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.99e-05	0.000109	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	1.98e-05	0.000108	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.96e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	1.96e-05	0.000107	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	1.94e-05	0.000106	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.93e-05	0.000105	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.91e-05	0.000104	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	1.91e-05	0.000104	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.86e-05	0.000102	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.85e-05	0.000101	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	1.82e-05	9.93e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.8e-05	9.83e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.79e-05	9.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.77e-05	9.68e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	1.72e-05	9.36e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—adrenal gland cancer	1.7e-05	9.25e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	1.69e-05	9.24e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.67e-05	9.12e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	1.66e-05	9.06e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.63e-05	8.92e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	1.63e-05	8.87e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.61e-05	8.78e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.6e-05	8.76e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—adrenal gland cancer	1.6e-05	8.73e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.6e-05	8.72e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.57e-05	8.59e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.55e-05	8.47e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	1.53e-05	8.34e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	1.53e-05	8.33e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.52e-05	8.31e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.47e-05	8.05e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.47e-05	8.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.46e-05	7.99e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—adrenal gland cancer	1.44e-05	7.86e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	1.43e-05	7.79e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—adrenal gland cancer	1.42e-05	7.75e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	1.4e-05	7.67e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.35e-05	7.38e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.3e-05	7.07e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	1.28e-05	7e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.27e-05	6.95e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.27e-05	6.95e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.27e-05	6.94e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	1.25e-05	6.81e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	1.24e-05	6.76e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	1.23e-05	6.72e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	1.2e-05	6.54e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	1.18e-05	6.44e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-05	6.33e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.09e-05	5.93e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	1.07e-05	5.84e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—adrenal gland cancer	1.07e-05	5.83e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	1.05e-05	5.72e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.04e-05	5.7e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	9.73e-06	5.31e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.33e-06	4.55e-05	CbGpPWpGaD
